Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Silverman

Showing results (751-760 of 846) with videos related to

Pageof 85
Sort By:
The Journal of Infectious Diseases|September 1, 1985
Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndromeO T Preble, A H Rook, R Steis, et al.
Investigative Ophthalmology & Visual Science|October 25, 2023
Ultrasound Assessment of Gaze-induced Posterior Eyewall Deformation in Highly Myopic EyesKai Xiong Cheong, Shen Yi Lim, Yee Shan Dan, et al.
Retrovirology|August 19, 2010
Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studiesXiaoxing Qiu, Priscilla Swanson, Ka-Cheung Luk, et al.
Clinical Lymphoma & Myeloma|November 21, 2007
Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphomaGregory A Wiseman, Peter S Conti, Katie Vo, et al.
The EMBO Journal|April 24, 2020
Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell deathAnna A Kondratova, HyeonJoo Cheon, Beihua Dong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
ROC and localization ROC analyses of lesion detection in whole-body FDG PET: effects of acquisition mode, attenuation correction and reconstruction algorithmT H Farquhar, J Llacer, C K Hoh, et al.
Nature Medicine|December 24, 2002
Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathwaysWolfgang W Leitner, Leroy N Hwang, Michael J deVeer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2002
The impact of PET on the management of lung cancer: the referring physician's perspectiveMarc A Seltzer, Cecelia S Yap, Daniel H Silverman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2005
A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase LKrishnamurthy Malathi, Jayashree M Paranjape, Elena Bulanova, et al.
The American Journal of Cardiology|August 14, 2003
Association between cardiac tumors and tuberous sclerosis in the fetus and neonateWayne Tworetzky, Doff B McElhinney, Rene Margossian, et al.
Pageof 85

Showing results (751-760 of 846) with videos related to

Sort By:
Pageof 85
The Journal of Infectious Diseases|September 1, 1985
Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndromeO T Preble, A H Rook, R Steis, et al.
Investigative Ophthalmology & Visual Science|October 25, 2023
Ultrasound Assessment of Gaze-induced Posterior Eyewall Deformation in Highly Myopic EyesKai Xiong Cheong, Shen Yi Lim, Yee Shan Dan, et al.
Retrovirology|August 19, 2010
Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studiesXiaoxing Qiu, Priscilla Swanson, Ka-Cheung Luk, et al.
Clinical Lymphoma & Myeloma|November 21, 2007
Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphomaGregory A Wiseman, Peter S Conti, Katie Vo, et al.
The EMBO Journal|April 24, 2020
Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell deathAnna A Kondratova, HyeonJoo Cheon, Beihua Dong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
ROC and localization ROC analyses of lesion detection in whole-body FDG PET: effects of acquisition mode, attenuation correction and reconstruction algorithmT H Farquhar, J Llacer, C K Hoh, et al.
Nature Medicine|December 24, 2002
Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathwaysWolfgang W Leitner, Leroy N Hwang, Michael J deVeer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2002
The impact of PET on the management of lung cancer: the referring physician's perspectiveMarc A Seltzer, Cecelia S Yap, Daniel H Silverman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2005
A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase LKrishnamurthy Malathi, Jayashree M Paranjape, Elena Bulanova, et al.
The American Journal of Cardiology|August 14, 2003
Association between cardiac tumors and tuberous sclerosis in the fetus and neonateWayne Tworetzky, Doff B McElhinney, Rene Margossian, et al.
Pageof 85